Abstract
Many classes of drugs, their interaction pathways and gene targets are known to play a role in drug induced liver injury (DILI). Pharmacogenomics research to understand the impact of genetic variation on how patients respond to drugs may help explain some of the variability observed in the occurrence of adverse drug reactions (ADR) such as DILI. The goal of this project is to combine rich genotype and phenotype data to better understand these scenarios. We consider similarities between drugs, similarities between drug targets, drug-pathway-gene interactions, etc. Links to the patients will include patient drug usage, ADR, disease outcomes, etc. We will develop appropriate protocols to create these rich datasets and methods to identify patterns in graphs for explanation and prediction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Anderson, P., Thor, A., Benik, J., Raschid, L., Vidal, M.E.: Pang - finding patterns in annotation graphs. In: Proceedings of the ACM Conference on the Management of Data (SIGMOD) (2012)
Aronson, A.R., Lang, F.-M.: An overview of metamap: historical perspective and recent advances. J. Am. Med. Inform. Assoc. 17(3), 229–236 (2010)
Björnsson, E., Jacobsen, E.I., Kalaitzakis, E.: Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J. Hepatol. 56(2), 374–380 (2012)
Bleakley, K., Yamanishi, Y.: Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics 25(18), 2397–2403 (2009)
Ding, H., Takigawa, I., Mamitsuka, H., Zhu, S.: Similarity-based machine learning methods for predicting drug-target interactions: a brief review. Briefings Bioinfor. 15, 734–747 (2013)
Fakhraei, S., Huang, B., Raschid, L., Getoor, L.: Network-based drug-target interaction prediction with probabilistic soft logic. IEEE/ACM Trans. Comput. Biol. Bioinfor. 11, 775–787 (2014)
Fiegenbaum, M., Silveira, F.R., Van der Sand, C.R., Van der Sand, L.C., Ferreira, M.E., Pires, R.C., Hutz, M.H.: The role of common variants of abcb1, cyp3a4, and cyp3a5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clin. Pharmacol. Ther. 78(5), 551–558 (2005)
Hattori, M., Okuno, Y., Goto, S., et al.: Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in metabolic pathways. J. Am. Chem. Soc. 125(39), 1853–1865 (2003)
Ho, J., Ghosh, J., Steinhubl, S., Stewart, W., Denny, J., Malin, B., Sun, J.: Limestone: high-throughput candidate phenotype generation via tensor factorization. J. Biomed. Inform. 52, 199–211 (2014)
Hoofnagle, J.H., Serrano, J., Knoben, J.E., Navarro, V.J.: Livertox: a website on drug-induced liver injury. Hepatology 57(3), 873–874 (2013)
Iyer, S., Harpaz, R., LePendu, P., Bauer-Mehren, A., Shah, N.: Mining clinical text for signals of adverse drug-drug interactions. JAMIA 21(2), 353–362 (2014)
Jiang, G., Liu, H., Solbrig, H., Chute, C.: Adepedia 2.0: integration of normalized adverse drug events (ades) knowledge from the UMLS. In: Proceedings of the AMIA Joint Summits on Translational Science, pp. 100–104 (2013)
Jiang, G., Wang, L., Liu, H., Solbrig, H., Chute, C.: Building a knowledge base of severe adverse drug events based on aers reporting data using semantic web technologies. Stud. Health Technol. Inform. 192, 496–500 (2013)
Jonquet, C., Shah, N., Youn, C., Callendar, C., Storey, M.-A., Musen, M.: Ncbo annotator: semantic annotation of biomedical data. In: International Semantic Web Conference (2009)
Kibbe, W.A., Arze, C., Felix, V., Mitraka, E., Bolton, E., Fu, G., Mungall, C.J., Binder, J.X., Malone, J., Vasant, D. et al.: Disease ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Res. D1071–D1078 (2014)
Köhler, S., Doelken, S.C., Mungall, C.J., Bauer, S., Firth, H.V., Bailleul-Forestier, I., Black, G.C., Brown, D.L., Brudno, M., Campbell, J., et al.: The human phenotype ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res. 1–9 (2013)
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A.C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al.: Drugbank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42(D1), D1091–D1097 (2014)
McKenney, J.M., Davidson, M.H., Jacobson, T.A., Guyton, J.R.: Final conclusions and recommendations of the national lipid association statin safety assessment task force. Am. J. Cardiol. 97(8), S89–S94 (2006)
Overby, C.L., Pathak, J., Gottesman, O., Haerian, K., Perotte, A., Murphy, S., Bruce, K., Johnson, S., Talwalkar, J., Shen, Y., et al.: A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J. Am. Med. Inform. Assoc. pages amiajnl-2013 E243–E252 (2013)
Palma, G., Vidal, M.-E., Raschid, L.: Drug-target interaction prediction using semantic similarity and edge partitioning. In: Mika, P., Tudorache, T., Bernstein, A., Welty, C., Knoblock, C., Vrandečić, D., Groth, P., Noy, N., Janowicz, K., Goble, C. (eds.) ISWC 2014, Part I. LNCS, vol. 8796, pp. 131–146. Springer, Heidelberg (2014)
Park, H., Choi, J.: V-model: a new perspective for EHR-phenotyping. BMC Medical Informatics and Decision Making, 14(90) (2014)
Robinson, P.N., Mundlos, S.: The human phenotype ontology. Clin. Genet. 77(6), 525–534 (2010)
Russmann, S., Jetter, A., Kullak-Ublick, G.: Pharmacogenomics of drug-induced liver injury. Heptology 52(2), 748–761 (2010)
Savova, G.K., Masanz, J.J., Ogren, P.V., Zheng, J., Sohn, S., Kipper-Schuler, K.C., Chute, C.G.: Mayo clinical text analysis and knowledge extraction system (ctakes): architecture, component evaluation and applications. J. Am. Med. Inform. Assoc. 17(5), 507–513 (2010)
Schriml, L.M., Arze, C., Nadendla, S., Chang, Y.-W.W., Mazaitis, M., Felix, V., Feng, G., Kibbe, W.A.: Disease ontology: a backbone for disease semantic integration. Nucleic Acids Res. 40(D1), D940–D946 (2012)
Urban, T., Daly, A., Aithal, G.: Genetic basis of drug-induced liver injury: present and future. Semin. Liver Inj. 34(2), 123–133 (2014)
Watkins, P.B., Dube, L.M., Walton-Bowen, K., Cameron, C.M., Kasten, L.E.: Clinical pattern of zileuton-associated liver injury. Drug Saf. 30(9), 805–815 (2007)
Whirl-Carrillo, M., McDonagh, E., Hebert, J., Gong, L., Sangkuhl, K., Thorn, C., Altman, R., Klein, T.E.: Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 92(4), 414–417 (2012)
Wilke, R.A., Moore, J.H., Burmester, J.K.: Relative impact of cyp3a genotype and concomitant medication on the severity of atorvastatin-induced muscle damage. Pharmacogenet. Genomics 15(6), 415–421 (2005)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Overby, C.L., Flores, A., Palma, G., Vidal, ME., Zotkina, E., Raschid, L. (2015). Combining Multiple Knowledge Sources: A Case Study of Drug Induced Liver Injury. In: Ashish, N., Ambite, JL. (eds) Data Integration in the Life Sciences. DILS 2015. Lecture Notes in Computer Science(), vol 9162. Springer, Cham. https://doi.org/10.1007/978-3-319-21843-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-21843-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21842-7
Online ISBN: 978-3-319-21843-4
eBook Packages: Computer ScienceComputer Science (R0)